Simulations Plus Inc.


SLP

Price

41.56


Change

0.04


High

NA


Low

40.9


Avg Volume

86,944


PE Ratio

82.46


52 Week High

52.69


52 Week Low

32.36



Profile

Simulations Plus, Inc. develops absorption, distribution, metabolism, excretion, and toxicity modeling and simulation software for the pharmaceutical and biotechnology, industrial chemicals, cosmetics, food ingredients, and herbicide industries. In September 2014, the company acquired Cognigen Corporation, a leading provider of clinical trial data analysis and consulting services. The company has produced specific proprietary software products, such as:



Quotes delayed 15 minutes for NASDAQ, and 20 minutes for NYSE and AMEX.

Data provided by IEX Cloud

About

Copyright © 2020 Finaza.IO. All Rights Reserved.